Fashek Christopher M's Form 4 filing
ENvue Medical, Inc. (FEED) · filed Jun 17, 2022
- Accession no.
- 0001493152-22-017164
- Filed
- Jun 17, 2022
- Trade date
- Nov 20, 2019
- Filing delay
- 940 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $50.0K. It was filed 940 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fashek Christopher MCIK 0001279063 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2019 | Common Stock | PPurchaseAcquired | +25,000 | $2.00 | +$50,000 | 25,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.